Literature DB >> 2917390

Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina.

H Miyagi1, H Yasue, K Okumura, H Ogawa, K Goto, S Oshima.   

Abstract

To examine whether or not magnesium suppresses coronary spasm, the effect of magnesium infusion on anginal attacks induced by hyperventilation was studied in 20 patients with variant angina. In all patients, anginal attacks associated with ischemic ST segment changes on the electrocardiogram were repeatedly induced by hyperventilation. The study was performed in the early morning successively for 3 days. On days 1 and 3 (control studies), 50 minutes before the hyperventilation test, a 5% glucose solution was infused as a placebo. On day 2 (magnesium study), 50 minutes before the hyperventilation test, magnesium sulfate (0.27 mM/kg body wt) was infused during a 20-minute period. During the control studies, anginal attack was induced by hyperventilation in all 20 patients, whereas during the magnesium study, anginal attack was induced by hyperventilation in only six (30%) of the 20 patients (p less than 0.001 vs. control studies). The changes in arterial blood pH and PCO2 caused by hyperventilation were not significant between the control study and the magnesium study. Mean serum magnesium concentration increased from 2.2 +/- 0.2 to 6.0 +/- 0.5 mg/dl immediately after infusing magnesium and was 4.5 +/- 0.6 mg/dl before the hyperventilation test during the magnesium study. We conclude that magnesium suppresses anginal attacks induced by hyperventilation in patients with variant angina.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917390     DOI: 10.1161/01.cir.79.3.597

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Magnesium and the myocardium.

Authors:  T A Millane; A J Camm
Journal:  Br Heart J       Date:  1992-11

2.  Intractable vasospastic angina.

Authors:  C Kurata; A Shimane
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 3.  Postsurgical complications in older patients. The role of pharmacological intervention.

Authors:  G Zuccalà; A Cocchi; G Gambassi; R Bernabei; P Carbonin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

Review 4.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  Hypomagnesemia during pediatric orthotopic liver transplantation.

Authors:  Toshihide Sato; Kazufumi Okamoto; Kenichi Ogata; Mitsuro Kurose; Michiaki Sadanaga; John Board
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

6.  Current advances in the understanding of coronary vasospasm.

Authors:  Ming-Jui Hung
Journal:  World J Cardiol       Date:  2010-02-26

7.  A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.

Authors:  Shi Hyun Rhew; Youngkeun Ahn; Eun Ae Cho; Min Sok Kim; Su Young Jang; Ki Hong Lee; Min Goo Lee; Keun Ho Park; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2013-01-31       Impact factor: 3.243

Review 8.  "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy.

Authors:  B Pitt
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

9.  Does Coronary Vasospasm Show a Better Prognosis in Out of Hospital Cardiac Arrest: Data from the Korean Cardiac Arrest Research Consortium (KoCARC) Registry.

Authors:  Hyo Eun Park; Sang-Hoon Na; Sang Do Shin; Jin Wi; Sang-Hyun Kim; Jinho Choi; Jong-Il Choi; Youngjin Cho; Myung-Jin Cha; Kyung-Hee Kim
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

Review 10.  Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management.

Authors:  Rajan Rehan; James Weaver; Andy Yong
Journal:  Life (Basel)       Date:  2022-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.